Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Medicine / Anrikning för kemoterapiresistent Ovarian…
JoVE Journal
Medicine

A subscription to JoVE is required to view this content.

JoVE Journal Medicine
Anrikning för kemoterapiresistent Ovarian cancerstamceller från humana cellinjer
Establishment of a Severe Dry Eye Model Using Complete Dacryoadenectomy in Rabbits
Journal (Medicine)
Establishment of a Severe Dry Eye Model Using Complete Dacryoadenectomy in Rabbits
Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging
Journal (Medicine)
Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging
 
Click here for the English version

Anrikning för kemoterapiresistent Ovarian cancerstamceller från humana cellinjer

Article DOI: 10.3791/51891-v • 11:50 min • September 10th, 2014
September 10th, 2014 •
1, 1, 1, 1
1Department of Biochemistry and Molecular Biology, Indiana University School of Medicine

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Cancer stamceller (CSCs) påverkar tumör återfall på grund av chemoresistance. Vi har optimerat ett protokoll för urval och expansion av CSCs från äggstockscancer cellinjer. Genom att behandla celler med kemoterapeutiska cisplatin och odling i en stamcell främja mediernas vi berikar för icke-vidhäftande CSC kulturer.

Tags

Medicin cancer stamceller stamcellsmarkörer äggstockscancer chemoresistance cisplatin cancer progression
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter